NL-OMON25911招募中不适用
Cytoreductive treatment of dabrafenib combined with trametinib to allow completesurgical resection in patients with BRAF mutated, prior unresectable stage III or IV melanoma
Antoni van Leeuwenhoek ziekenhuis0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- •1.Has provided signed informed consent.
排除标准
- •A potential subject who meets any of the following criteria will be excluded from participation in this study:
- •1. Known ocular or primary mucosal melanoma.
研究者
相似试验
已完成
2 期
Cytoreductive treatment of dabrafenib combined with trametinib to allow complete surgical resection in patients with BRAF mutated, prior unresectable stage III or IV melanomaskin cancermaligne melanoma10040900NL-OMON38944ederlands Kanker Instituut25
进行中（未招募）
不适用
A trial with patients who have a tumor that is too big to resect via operation, to treat them with systemic treatment to downsize the tumor, so that after 8 weeks the tumor can be resected and the patient is cured.unresectable stage III/IV melanomaMedDRA version: 14.1Level: HLTClassification code 10027156Term: Skin melanomas (excl ocular)System Organ Class: 100000004864EUCTR2013-002616-28-NLKI-AV
进行中（未招募）
不适用
CLOFARABINE/ARA-C TREATMENT COMBINED WITH REDUCED-INTENSITY CONDITIONING ALLOGENEIC STEM CELL TRANSPLANTATION FOR ACUTEMYELOID LEUKEMIA IN PRIMARY TREATMENT FAILURE - SET-RICTo improve the 2 year overall survival in patients with acute myeloid leukaemia (AML) in primary treatment failureEUCTR2009-015176-10-FRCHU de Nantes
尚未招募
2 期
Dasatinib treatment combination for fludarabine-refractory Chronic Lymphocytic Leukemia (CLL)chronic lymphocytic leukeniaB cell leukemia10024324NL-OMON37297AMC afdeling hematologie35
进行中（未招募）
1 期
A study to test a new drug for treating non-small cell lung cancerAdvanced non-small cell lung cancer and BRAF mutationsMedDRA version: 18.0Level: PTClassification code 10061873Term: Non-small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-001161-41-ITGlaxoSmithKline Research and Development Limited100